These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 3711667)
1. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+. Carney DF; Hammer CH; Shin ML J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667 [TBL] [Abstract][Full Text] [Related]
2. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process. Kim SH; Carney DF; Hammer CH; Shin ML J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349 [TBL] [Abstract][Full Text] [Related]
3. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. Carney DF; Koski CL; Shin ML J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432 [TBL] [Abstract][Full Text] [Related]
4. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. Carney DF; Lang TJ; Shin ML J Immunol; 1990 Jul; 145(2):623-9. PubMed ID: 2164064 [TBL] [Abstract][Full Text] [Related]
5. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis. Morgan BP; Imagawa DK; Dankert JR; Ramm LE J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758 [TBL] [Abstract][Full Text] [Related]
6. Membrane vesiculation protects erythrocytes from destruction by complement. Iida K; Whitlow MB; Nussenzweig V J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984 [TBL] [Abstract][Full Text] [Related]
7. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268 [TBL] [Abstract][Full Text] [Related]
8. Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. Ramm LE; Whitlow MB; Koski CL; Shin ML; Mayer MM J Immunol; 1983 Sep; 131(3):1411-5. PubMed ID: 6309963 [TBL] [Abstract][Full Text] [Related]
9. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore. Bhakdi S; Tranum-Jensen J J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488 [TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
11. The relationship between channel size and the number of C9 molecules in the C5b-9 complex. Ramm LE; Whitlow MB; Mayer MM J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. Papadimitriou JC; Ramm LE; Drachenberg CB; Trump BF; Shin ML J Immunol; 1991 Jul; 147(1):212-7. PubMed ID: 1904901 [TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte x C6 glioma cell hybrids. Shirazi Y; McMorris FA; Shin ML J Immunol; 1989 Jun; 142(12):4385-91. PubMed ID: 2542410 [TBL] [Abstract][Full Text] [Related]
14. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. MacKay SL; Dankert JR J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122 [TBL] [Abstract][Full Text] [Related]
15. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a. Hammer CH; Hänsch G; Gresham HD; Shin ML J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934 [TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421 [TBL] [Abstract][Full Text] [Related]
17. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593 [TBL] [Abstract][Full Text] [Related]
18. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. Cybulsky AV; Quigg RJ; Salant DJ J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914 [TBL] [Abstract][Full Text] [Related]
19. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119 [TBL] [Abstract][Full Text] [Related]
20. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Seifert PS; Hugo F; Hansson GK; Bhakdi S Lab Invest; 1989 Jun; 60(6):747-54. PubMed ID: 2659887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]